HealthEquity (NASDAQ:HQY) Director Sells $219,510.00 in Stock

HealthEquity, Inc. (NASDAQ:HQY) Director Gayle Furgurson Wellborn sold 2,439 shares of the stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $219,510.00. Following the completion of the transaction, the director owned 19,733 shares of the company’s stock, valued at $1,775,970. This represents a 11.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

HealthEquity Price Performance

HealthEquity stock opened at $85.21 on Thursday. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. The company has a market capitalization of $7.12 billion, a PE ratio of 31.91, a P/E/G ratio of 1.52 and a beta of 0.21. HealthEquity, Inc. has a 12 month low of $72.76 and a 12 month high of $116.65. The stock has a 50-day moving average price of $83.85 and a two-hundred day moving average price of $86.42.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, beating the consensus estimate of $1.11 by $0.13. The firm had revenue of $354.64 million during the quarter, compared to the consensus estimate of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.HealthEquity’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Analysts expect that HealthEquity, Inc. will post 3.84 EPS for the current year.

Analyst Ratings Changes

Several equities analysts have commented on HQY shares. Citigroup reiterated a “market outperform” rating on shares of HealthEquity in a research report on Monday. Barrington Research reiterated an “outperform” rating and issued a $110.00 target price on shares of HealthEquity in a research report on Friday, May 22nd. Wall Street Zen downgraded HealthEquity from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. BMO Capital Markets upgraded HealthEquity from a “market perform” rating to an “outperform” rating and raised their price objective for the stock from $85.00 to $105.00 in a research report on Thursday, April 9th. Finally, Barclays lowered their price objective on HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a research report on Wednesday, February 18th. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, HealthEquity presently has a consensus rating of “Moderate Buy” and an average price target of $110.57.

Hedge Funds Weigh In On HealthEquity

Hedge funds have recently made changes to their positions in the stock. Xponance Inc. lifted its holdings in HealthEquity by 0.8% during the third quarter. Xponance Inc. now owns 12,265 shares of the company’s stock worth $1,162,000 after acquiring an additional 102 shares during the period. Fifth Third Wealth Advisors LLC lifted its holdings in HealthEquity by 4.2% during the first quarter. Fifth Third Wealth Advisors LLC now owns 2,872 shares of the company’s stock worth $240,000 after acquiring an additional 116 shares during the period. Truist Financial Corp lifted its holdings in HealthEquity by 4.9% during the fourth quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock worth $232,000 after acquiring an additional 119 shares during the period. Fiduciary Trust Co lifted its holdings in HealthEquity by 3.4% during the third quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock worth $348,000 after acquiring an additional 120 shares during the period. Finally, Larson Financial Group LLC lifted its holdings in HealthEquity by 24.4% during the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock worth $60,000 after acquiring an additional 123 shares during the period. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.